Azimuth Capital Management’s Biogen BIIB Stock Holding History

Azimuth Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-14,372	Closed	-$5.8M	–	282
2015 Q2	$5.8M	Sell	14,372 -4,640	-24%	-$1.86M	0.56%	57
2015 Q1	$8.03M	Buy	19,012 +3,935	+26%	+$1.55M	0.78%	36
2014 Q4	$5.12M	Buy	15,077 +1,615	+12%	+$522K	0.53%	65
2014 Q3	$4.45M	Sell	13,462 -5,680	-30%	-$1.87M	0.49%	72
2014 Q2	$6.04M	Buy	19,142 +1	+0%	+$301	0.67%	46
2014 Q1	$5.86M	Sell	19,141 -846	-4%	-$269K	0.71%	46
2013 Q4	$5.59M	Sell	19,987 -1,952	-9%	-$505K	0.67%	47
2013 Q3	$5.28M	Buy	21,939 +139	+0.6%	+$31.1K	0.73%	39
2013 Q2	$4.69M	Buy	+21,800	New	+$4.66M	0.83%	34

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Azimuth Capital Management's BIIB Position: Q3 2015 in Review

Azimuth Capital Management sold out of Biogen (BIIB) in Q3 2015, closing a stake of 14,372 shares — an estimated $5.8M sold.

Azimuth Capital Management first reported a position in BIIB in Q2 2013 and held it in 9 quarters. The position peaked at $8.03M in Q1 2015. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

Azimuth Capital Management reported no remaining Biogen position as of Q3 2015 after selling out during the quarter.
Azimuth Capital Management sold 14,372 Biogen shares in Q3 2015, an estimated $5.8M.
Azimuth Capital Management first reported a position in Biogen in Q2 2013 and held it in 9 quarters.
Azimuth Capital Management's Biogen position peaked at $8.03M in Q1 2015.
924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Azimuth Capital Management's 13F filing for Q3 2015, filed 12 Nov 2015.